Wordt geladen...

Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9

The anticancer properties of epigallocatechin-3-gallate (EGCG) are documented in the treatment of several types of cancer; however, there is no relevant evidence for its efficacy in the treatment of renal cell carcinoma (RCC). In the present study, the therapeutic effects of EGCG in vitro were inves...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Exp Ther Med
Hoofdauteurs: CHEN, SHAO-JUN, YAO, XU-DONG, PENG, BO, XU, YUN-FEI, WANG, GUANG-CHUN, HUANG, JIANHUA, LIU, MIN, ZHENG, JUN-HUA
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812156/
https://ncbi.nlm.nih.gov/pubmed/27073430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3050
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!